Geneflux® Biosciences is a technology driven and market driven molecular diagnostics company, passionately involved in product-oriented research, development and manufacturing of molecular diagnostics services. We are a “Bionexus Status” and ISO 9001:2008, ISO 17025:2005, and ISO 13845:2003 certified company with a very well established quality management system and customer friendly business model. We are truly “multinational company” consisting of both Malaysian and foreign shareholders, supported by an aggressive team of scientists, technologists and entrepreneurs. We have a state of art molecular diagnostic laboratory (5000 sq.ft built-in area), which is very well equipped to analyze 1000 clinical samples everyday using PCR (Polymerase Chain Reaction) technology. We strongly believe in public-private partnership and participate in collaborative networks to leverage on the infrastructure and capabilities of Malaysian universities (under BioNexus Program). We have received “Certficate of Achievement” from the Ministry of Science, Technology and Innovation (MOSTI)” Government of Malaysia for the successful completion of commercial development and validation of MyDenkit, a PCR based for detection and genotyping of dengue virus in 6 international centers. We are recipient of a prestigious award by “Frost & Sullivan” as the “2010 Asia Pacific Frost & Sullivan Niche Company of the year Award in Molecular Diagnostics” and “ 2012 Frost & Sullivan Southeast Asian Fastest Growing Company in Molecular Diagnostics for Infectious Disease”. We are enrolled to “RCPA Quality Assurance Programs Private Limited” Australia and has participated in inter laboratory quality assurance scheme conducted by Institute of Medical research (IMR) Malaysia. The Management is committed to purse the dream of providing the best of diagnostic services at an affordable rate to the private and public hospitals in Malaysia. We thrive to accomplish customer satisfaction by providing best turn-around-time (we operate seven days of the week). We are eager to collaborate with local and international research centers and provide specialized support in the translational research towards emerging areas of technologies, namely Microarray Technology, Personalized Medicine and Next generation sequencing systems.
